Abdel A. Mohamed

Array ( [id] => 3940357 [patent_doc_number] => 05973112 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Collagen mimics' [patent_app_type] => 1 [patent_app_number] => 8/918223 [patent_app_country] => US [patent_app_date] => 1997-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3986 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/973/05973112.pdf [firstpage_image] =>[orig_patent_app_number] => 918223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4027828 [patent_doc_number] => 05883231 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Artificial menses fluid' [patent_app_type] => 1 [patent_app_number] => 8/916993 [patent_app_country] => US [patent_app_date] => 1997-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1543 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/883/05883231.pdf [firstpage_image] =>[orig_patent_app_number] => 916993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998541 [patent_doc_number] => 05858696 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Method and compositions to assess oxidative stress in vivo' [patent_app_type] => 1 [patent_app_number] => 8/912440 [patent_app_country] => US [patent_app_date] => 1997-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 7774 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858696.pdf [firstpage_image] =>[orig_patent_app_number] => 912440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359836 [patent_doc_number] => 06255278 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Composition containing pooled transferrins as an active principle for the induction of immune tolerance against antigens' [patent_app_type] => 1 [patent_app_number] => 8/836389 [patent_app_country] => US [patent_app_date] => 1997-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5841 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255278.pdf [firstpage_image] =>[orig_patent_app_number] => 836389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4051539 [patent_doc_number] => 05969106 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Self-aligning peptides modeled on human elastin and other fibrous proteins' [patent_app_type] => 1 [patent_app_number] => 8/911364 [patent_app_country] => US [patent_app_date] => 1997-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 10177 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/969/05969106.pdf [firstpage_image] =>[orig_patent_app_number] => 911364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769355 [patent_doc_number] => 05773417 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/906828 [patent_app_country] => US [patent_app_date] => 1997-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 5271 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773417.pdf [firstpage_image] =>[orig_patent_app_number] => 906828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3761745 [patent_doc_number] => 05851995 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Anti-obesity proteins' [patent_app_type] => 1 [patent_app_number] => 8/905694 [patent_app_country] => US [patent_app_date] => 1997-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7824 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851995.pdf [firstpage_image] =>[orig_patent_app_number] => 905694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4013365 [patent_doc_number] => 05962651 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Modified hemoglobin and its use as a component of an artificial blood substitute' [patent_app_type] => 1 [patent_app_number] => 8/903930 [patent_app_country] => US [patent_app_date] => 1997-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 2284 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962651.pdf [firstpage_image] =>[orig_patent_app_number] => 903930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3789718 [patent_doc_number] => 05840849 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Blends of collagen type I and collagen type III for food casings' [patent_app_type] => 1 [patent_app_number] => 8/902162 [patent_app_country] => US [patent_app_date] => 1997-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1822 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840849.pdf [firstpage_image] =>[orig_patent_app_number] => 902162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3943092 [patent_doc_number] => 05981710 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Therapeutic hemoglobin composition having isotropically increased size' [patent_app_type] => 1 [patent_app_number] => 8/896743 [patent_app_country] => US [patent_app_date] => 1997-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10481 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 257 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981710.pdf [firstpage_image] =>[orig_patent_app_number] => 896743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3892888 [patent_doc_number] => 05834596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Process for purifying ApoA or ApoE' [patent_app_type] => 1 [patent_app_number] => 8/875125 [patent_app_country] => US [patent_app_date] => 1997-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7742 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834596.pdf [firstpage_image] =>[orig_patent_app_number] => 875125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3978264 [patent_doc_number] => 05905140 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-18 [patent_title] => 'Selective acylation method' [patent_app_type] => 1 [patent_app_number] => 8/889262 [patent_app_country] => US [patent_app_date] => 1997-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6277 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/905/05905140.pdf [firstpage_image] =>[orig_patent_app_number] => 889262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3986680 [patent_doc_number] => 05985261 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Use of thioredoxin-like molecules for induction of MnSOD to treat oxidative damage' [patent_app_type] => 1 [patent_app_number] => 8/883804 [patent_app_country] => US [patent_app_date] => 1997-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 9907 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985261.pdf [firstpage_image] =>[orig_patent_app_number] => 883804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3969099 [patent_doc_number] => 05886155 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Purification of miraculin glycoprotein using tandem hydrophobic interaction chromatography' [patent_app_type] => 1 [patent_app_number] => 8/878068 [patent_app_country] => US [patent_app_date] => 1997-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6654 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886155.pdf [firstpage_image] =>[orig_patent_app_number] => 878068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3927364 [patent_doc_number] => 05877148 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Treatment of cancer with human chorionic gonadotropin' [patent_app_type] => 1 [patent_app_number] => 8/869603 [patent_app_country] => US [patent_app_date] => 1997-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 7341 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877148.pdf [firstpage_image] =>[orig_patent_app_number] => 869603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808105 [patent_doc_number] => 05831026 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Process for purifying factor VIII' [patent_app_type] => 1 [patent_app_number] => 8/809756 [patent_app_country] => US [patent_app_date] => 1997-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6725 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831026.pdf [firstpage_image] =>[orig_patent_app_number] => 809756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924475 [patent_doc_number] => 05945399 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma' [patent_app_type] => 1 [patent_app_number] => 8/862785 [patent_app_country] => US [patent_app_date] => 1997-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10474 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945399.pdf [firstpage_image] =>[orig_patent_app_number] => 862785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3810975 [patent_doc_number] => 05811521 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Multifunctional crosslinking reagents for hemoglobin, and crosslinked hemoglobin conjugates' [patent_app_type] => 1 [patent_app_number] => 8/793087 [patent_app_country] => US [patent_app_date] => 1997-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 6746 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811521.pdf [firstpage_image] =>[orig_patent_app_number] => 793087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831171 [patent_doc_number] => 05814471 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Luciferase inhibitor compositions and methods of using same' [patent_app_type] => 1 [patent_app_number] => 8/831781 [patent_app_country] => US [patent_app_date] => 1997-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 10994 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814471.pdf [firstpage_image] =>[orig_patent_app_number] => 831781 [rel_patent_id] =>[rel_patent_doc_number] =>)